Rubius Therapeutics, Inc. Current Ratio 2018-2022 | RUBY
Rubius Therapeutics, Inc. current ratio from 2018 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2022-12-31 | $0.02B | $0.01B | 2.54 |
| 2022-09-30 | $0.11B | $0.03B | 3.40 |
| 2022-06-30 | $0.14B | $0.03B | 4.63 |
| 2022-03-31 | $0.18B | $0.03B | 6.23 |
| 2021-12-31 | $0.23B | $0.04B | 6.63 |
| 2021-09-30 | $0.27B | $0.03B | 8.74 |
| 2021-06-30 | $0.30B | $0.03B | 12.12 |
| 2021-03-31 | $0.34B | $0.03B | 10.96 |
| 2020-12-31 | $0.18B | $0.03B | 6.52 |
| 2020-09-30 | $0.21B | $0.03B | 7.15 |
| 2020-06-30 | $0.24B | $0.03B | 8.44 |
| 2020-03-31 | $0.25B | $0.03B | 8.99 |
| 2019-12-31 | $0.29B | $0.03B | 8.57 |
| 2019-09-30 | $0.33B | $0.03B | 9.83 |
| 2019-06-30 | $0.37B | $0.02B | 17.27 |
| 2019-03-31 | $0.39B | $0.02B | 18.64 |
| 2018-12-31 | $0.41B | $0.02B | 20.72 |
| 2018-09-30 | $0.41B | $0.02B | 25.77 |
| 2018-06-30 | $0.18B | $0.02B | 12.26 |
| 2018-03-31 | $0.00B | 0.00 | |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
